(Q57714746)
Statements
Phase II evaluation of oral estramustine, oral etoposide, and intravenous paclitaxel in patients with hormone-sensitive prostate adenocarcinoma (English)
Rodney L Dunn
Bruce G Redman
Karin B Olson
Judith E Fardig
scientific article published on 01 June 2007